-
Jastreboff AM, le Roux CW, Stefanski A, Aronne LJ, Halpern B, Wharton S, Wilding JPH, Perreault L, Zhang S, Battula R, Bunck MC, Ahmad NN, Jouravskaya I; SURMOUNT-1 Investigators.
Tirzepatide for Obesity Treatment and Diabetes Prevention The New England Journal of Medicine
-
McClelland J, Gallagher D, Moore SE, McGirr C, Beeken RJ, Croker H, Eastwood KA, O'Neill RF, Woodside JV, McGowan L, McKinley MC.
Development of a habit-based intervention to support healthy eating and physical activity behaviours for pregnant women with overweight or obesity: Healthy Habits in Pregnancy and Beyond (HHIPBe) BMC Pregnancy Childbirth
-
Abdel Rahman A, Kassem NOF, Edwards MLE, Abdallah B, Abdel Malak R.
Adding sugar to children’s beverages: a theory of planned behavior study of Lebanese mothers Health Promot Int
-
Hyassat D, Al-Refai A, Khader YS, Juweid ME, AlSharaydeh S, Layyous N, Aljabiry H, AlDurgham A, Baqain LZ, Abu Summaqa J, Al-Shimi R, Atieh FM, Mahasneh A, Alaraj S, Al-Wakfi A, Mahafza O, El-Khateeb M, Ajlouni K.
Metabolic syndrome among patients with type 2 diabetes in Jordan: A cross-sectional study Medicine (Baltimore)
-
McDonnell Murray R, Peelo C, Duffy F.
Navigating the food environment: Experiences of reduced calorie interventions to manage Type 2 Diabetes Mellitus J Health Psychol
- Coral DE, Smit F, Farzaneh A, Gieswinkel A, Tajes JF, Sparsø T, Delfin C, Bauvin P, Wang K, Temprosa M, De Cock D, Blanch J, Fernández-Real JM, Ramos R, Ikram MK, Gomez MF, Kavousi M, Panova-Noeva M, Wild PS, van der Kallen C, Adriaens M, van Greevenbroek Author Correction: Subclassification of obesity for precision prediction of cardiometabolic diseases Nat Med
-
Zhou XD, Chen QF, Targher G, Byrne CD, Mantzoros CS, Zhang H, Lonardo A, Lip GYH, Porta G, Misra A, Robertson AG, Luo F, Alisi A, Yang W, El-Shabrawi M, Al Momani H, Somers VK, Katsouras CS, Méndez-Sánchez N, Lefere S, Szepietowski O, Sung KC, Hui Ng NB,
Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15-39, 1990-2021 Clin Nutr
-
Bitterlich LM, Tunstead C, Hogan AE, Ankrum JA, English K.
Mesenchymal stromal cells can block palmitate training of macrophages via cyclooxygenase-2 and interleukin-1 receptor antagonist Cytotherapy
-
Siriyotha S, Anothaisintawee T, Looareesuwan P, Nimitphong H, McKay GJ, Attia J, Thakkinstian A.
Effectiveness of glucagon-like peptide-1 receptor agonists for reduction of body mass index and blood glucose control in patients with type 2 diabetes mellitus and obesity: A retrospective cohort study and difference-in-difference analysis BMJ Open
- le Roux CW, Steen O, Lucas KJ, Ekinci EI, Startseva E, Unseld A, Hussain SA, Hennige AM. Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves blood pressure in adults with obesity: A post hoc analysis from a randomized, placebo-controlled, dose-finding, phase 2 trial Diabetes Obes Metab